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Received 5 October 2012; received in revised form 16 October 2012; accepted 19 October 2012A 33-year-old man was admitted with cough, chest
discomfort and weight loss for 1 month. There was no
significant past medical history. The patient smoked 20
cigarettes/day for 10 years. On admission, the lungs were
clear to auscultation. Laboratory data showed a mildly
decreased level of hemoglobin (11.0 g/dL) and other
laboratory tests revealed no abnormal findings. HIV anti-
body was negative. A chest X-ray showed mediastinal mass
in the right upper zone. Contrast chest computed tomog-
raphy demonstrated the right paratracheal lymph nodes
with peripheral rim enhancement and the normal lung
parenchyma. Bronchoscopy revealed a mass with caseating
material eroding through the right tracheal wall and
a biopsy was done (Fig. 1). Histopathological examination
revealed granulomatous inflammation with necrosis. A
modified Ziehl-Neelsen stain was positive for acid-fast
bacilli (AFB) and polymerase-chain reaction was positive
for Mycobacterium tuberculosis. Sputum and bronchial
washing fluid specimens were positive for AFB on smearConflicts of interest: The authors have no conflicts of interest
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http://dx.doi.org/10.1016/j.jfma.2012.10.014examination. The patient was commenced on therapy with
isoniazid, rifampin, pyrazinamide, and ethambutol for
tuberculous lymphadenitis. Sputum and bronchial washing
fluid culture grew M. tuberculosis resistant to isoniazid,
rifampin, ethambutol, kanamycin, amikacin, ofloxacin, and
rifabutin. After culture demonstrated extensively drug-
resistant tuberculosis (XDR-TB), treatment was changed
to streptomycin, pyrazinamide, moxifloxacin, cycloserine,
and prothionamide. Sputum specimens obtained 1 month
later were negative for AFB. The patient is under close
follow-up and to date is tolerating anti-TB therapy, which is
planned to continue for a minimum of 18 months.
Tuberculous lymphadenitis is among the most common
presentations of extrapulmonary TB. Tuberculous medias-
tinal lymphadenitis is visible on the chest radiograph in up
to 90% of patients. Computed tomography can help identify
the presence of adenopathy characterized by central low
attenuation with peripheral rim enhancement on enhanced
scans. Tuberculous mediastinal lymphadenitis occasionally
compresses or erodes into the surrounding structures such
as aorta, superior vena cava, esophagus, and recurrent
laryngeal nerve. However, tuberculous mediastinal lymph-
adenitis eroding into the trachea is rare. There has been
one report of tuberculous lymphadenopathy communi-
cating directly with the trachea revealed by postmortem
examination.1& Formosan Medical Association. All rights reserved.
Figure 1 Flexible bronchoscopy revealing a mass with
necrotic material eroding through the right tracheal wall.
XDR-TB presenting as primary lymphadenitis 765XDR-TB, defined as resistance to both isoniazid and
rifampin with additional resistance to at least one fluo-
roquinolone and one injectable agent (amikacin, capreo-
mycin, or kanamycin), was first reported in 2006 and has
now been documented on six continents.2 Although XDR-TB
has engaged considerable attention in recent years with the
increasing number of cases and high rates of mortality,3XDR-TB involving extrapulmonary sites is little known. In
extrapulmonary TB, obtaining a specimen requires an
invasive procedure and the specimen’s AFB test has low
sensitivity and specificity.4 Because of lack of knowledge
regarding drug resistance, physicians use anti-TB drugs
empirically, and they have problems with in deterioration
of clinical progression. The HIV epidemic has been associ-
ated with an increased proportion of miliary, disseminated,
and extrapulmonary TB cases as well as an increase in the
total incidence of TB. In a study of predominately HIV-
infected patients, of the 12 positive M. tuberculosis
cultures from lymph nodes, one (8%) was XDR-TB.5 Drug-
susceptibility testing should be performed in a patient
with tuberculous lymphadenitis even in a nonendemic area
of HIV infection.References
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